Medco Contracts Will Minimize Impact Of Pricing Changes, PBM Says
Medco believes the structure of its contracts will shield the company from any fallout from changes to drug benchmark prices brought on by a proposed legal settlement by drug price publisher First DataBank
You may also be interested in...
Express Scripts' review of the First DataBank suit on average wholesale price mark-ups suggests that its major challenge will be managing client expectations about the impact of the suit's proposed settlement
Adiana uses a polymer matrix insert to block the fallopian tubes instead of a metal coil, offering a benefit over Essure, which carries a perforation risk on implantation, Hologic exec says.
The results show that cardiac resynchronization defibrillators "slow the progression of heart failure in asymptomatic and mildly symptomatic patients," potentially expanding the market by $600 million.